The Department of Health and Human Services yesterday released a fact sheet summarizing federal efforts to address Long COVID — the signs, symptoms and conditions that can continue or develop after initial COVID-19 or SARS-CoV-2 infection. Among other actions, a National Academies of Science, Engineering, and Medicine committee this month will launch a series of public meetings with stakeholders to receive input as it works to refine the federal definition of Long COVID, which will impact how clinicians diagnose and treat it. Also this month, the Agency for Healthcare Research and Quality plans to announce $9 million in funding to help existing Long COVID clinics expand and implement care delivery models.

Related News Articles

Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…